Our study has limitations; first, the study cohort consisted of HIV+ individuals with low CD4 nadir, and exposure to older ART regimens, so it is possible that some differences we found between cognitive impairment versus normal cognition could be confounded by factors other rather than cognitive status. The gene discussed is CD4; the disease is Cognitive impairment.